Clinical Trial Update: A Study of RO4998452 in Type 2 Diabetes Patients With Varying Degrees of Renal Impairment [Phase 1]

View source ↗

Summary

Phase 1 study evaluating RO4998452 in adults with type 2 diabetes mellitus and varying degrees of renal impairment; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• RO4998452

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Diabetes Mellitus Type 2 | Phase 1 | Status: COMPLETED